Back to newsBeOne Medicines: TD Cowen raises target price to $477 from $454OONC•2026-11-06TD Cowen raised its target price for BeOne Medicines to $477 from $454.Related NewsNNIKE, INC.: RBC cuts target price to $39 from $40NKE•2026-11-06ONasdaq trade halt continues; reason not available at 03:58 a.m.OST•2026-11-06GGoldman Sachs cuts total voting rights in K+S to 9.51% from 10.05%GS•2026-11-06AAlbemarle: RBC cuts target price to $119 from $129ALB•2026-11-06EGerman industrial output rises 0.7% in SeptemberEWG•2026-11-06
ONC•ONC•ONC•ONC•
